Header Logo

Connection

PHILIP LUPO to Child

Back to Details
This is a "connection" page, showing publications PHILIP LUPO has written about Child.
PHILIP LUPO
Connection Strength
3.234
Child
  1. Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
    View in: PubMed
    Score: 0.058
  2. Incidence and Survival of Children and Adolescents With Wilms Tumor, United States, 2001-2020. Cancer Med. 2025 Feb; 14(3):e70598.
    View in: PubMed
    Score: 0.058
  3. Risk of carcinomas among children and adolescents with birth defects. Cancer Epidemiol. 2025 Apr; 95:102748.
    View in: PubMed
    Score: 0.058
  4. Overview of the etiology of childhood cancer and future directions. Curr Opin Pediatr. 2025 Feb 01; 37(1):59-66.
    View in: PubMed
    Score: 0.058
  5. Residential proximity to oil and gas developments and childhood cancer survival. Cancer. 2024 Nov 01; 130(21):3724-3733.
    View in: PubMed
    Score: 0.056
  6. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group. JAMA Netw Open. 2024 03 04; 7(3):e244170.
    View in: PubMed
    Score: 0.055
  7. The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer. Pediatr Blood Cancer. 2024 May; 71(5):e30924.
    View in: PubMed
    Score: 0.055
  8. Role of non-chromosomal birth defects on the risk of developing childhood Hodgkin lymphoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2024 Mar; 71(3):e30822.
    View in: PubMed
    Score: 0.054
  9. Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children. Cancer. 2024 02 01; 130(3):467-475.
    View in: PubMed
    Score: 0.053
  10. Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15?000 leukemia cases and 46?000 controls from the Childhood Cancer and Leukemia International Consortium. Int J Cancer. 2024 Feb 01; 154(3):434-447.
    View in: PubMed
    Score: 0.053
  11. Fetal growth and pediatric cancer: A pan-cancer analysis in 7000 cases and 37?000 controls. Int J Cancer. 2024 01 01; 154(1):41-52.
    View in: PubMed
    Score: 0.053
  12. Children's Oncology Group's 2023 blueprint for research: Epidemiology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30566.
    View in: PubMed
    Score: 0.052
  13. Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group. J Natl Cancer Inst. 2023 06 08; 115(6):733-741.
    View in: PubMed
    Score: 0.052
  14. Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO Precis Oncol. 2022 12; 6:e2200239.
    View in: PubMed
    Score: 0.050
  15. The risks of birth defects and childhood cancer with conception by assisted reproductive technology. Hum Reprod. 2022 10 31; 37(11):2672-2689.
    View in: PubMed
    Score: 0.050
  16. Differential newborn DNA methylation among individuals with complex congenital heart defects and childhood lymphoma. Birth Defects Res. 2022 12 01; 114(20):1434-1439.
    View in: PubMed
    Score: 0.050
  17. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001-2017. Cancer Med. 2023 02; 12(3):3644-3656.
    View in: PubMed
    Score: 0.049
  18. An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report. Cancer. 2022 07 15; 128(14):2760-2767.
    View in: PubMed
    Score: 0.048
  19. Associations of demographic and perinatal factors with childhood neuroblastoma in Texas, 1995-2011. Cancer Epidemiol. 2022 06; 78:102165.
    View in: PubMed
    Score: 0.048
  20. Comprehensively evaluating cancer survival in children with birth defects: a population-based assessment. Cancer Causes Control. 2022 Mar; 33(3):483-488.
    View in: PubMed
    Score: 0.047
  21. Residence in a Hispanic Enclave Is Associated with Inferior Overall Survival among Children with Acute Lymphoblastic Leukemia. Int J Environ Res Public Health. 2021 09 02; 18(17).
    View in: PubMed
    Score: 0.046
  22. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Natl Cancer Inst. 2021 07 01; 113(7):875-883.
    View in: PubMed
    Score: 0.045
  23. Using primary teeth and archived dried spots for exposomic studies in children: Exploring new paths in the environmental epidemiology of pediatric cancer. Bioessays. 2021 09; 43(9):e2100030.
    View in: PubMed
    Score: 0.045
  24. Risks of nonchromosomal birth defects, small-for-gestational age birthweight, and prematurity with in vitro fertilization: effect of number of embryos transferred and plurality at conception versus at birth. J Assist Reprod Genet. 2021 Apr; 38(4):835-846.
    View in: PubMed
    Score: 0.044
  25. A Comprehensive Assessment of Co-occurring Birth Defects among Infants with Non-Syndromic Anophthalmia or Microphthalmia. Ophthalmic Epidemiol. 2021 10; 28(5):428-435.
    View in: PubMed
    Score: 0.044
  26. Cancer Progress and Priorities: Childhood Cancer. Cancer Epidemiol Biomarkers Prev. 2020 06; 29(6):1081-1094.
    View in: PubMed
    Score: 0.042
  27. Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases. Cancer. 2020 08 01; 126(15):3483-3492.
    View in: PubMed
    Score: 0.042
  28. Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia. EBioMedicine. 2019 Oct; 48:49-57.
    View in: PubMed
    Score: 0.040
  29. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment. Cancer. 2019 10 15; 125(20):3623-3630.
    View in: PubMed
    Score: 0.040
  30. Maternal Residential Proximity to Major Roadways and the Risk of Childhood Acute Leukemia: A Population-Based Case-Control Study in Texas, 1995-2011. Int J Environ Res Public Health. 2019 06 07; 16(11).
    View in: PubMed
    Score: 0.039
  31. Quantifying survival disparities among children diagnosed with cancer on a global scale. Lancet Oncol. 2019 07; 20(7):894-896.
    View in: PubMed
    Score: 0.039
  32. Genetic Predisposition to Childhood Cancer in the Genomic Era. Annu Rev Genomics Hum Genet. 2019 08 31; 20:241-263.
    View in: PubMed
    Score: 0.039
  33. Perinatal and familial risk factors for soft tissue sarcomas in childhood through young adulthood: A population-based assessment in 4 million live births. Int J Cancer. 2020 02 01; 146(3):791-802.
    View in: PubMed
    Score: 0.039
  34. DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Genes Chromosomes Cancer. 2019 01; 58(1):52-59.
    View in: PubMed
    Score: 0.038
  35. Schaaf-Yang syndrome overview: Report of 78 individuals. Am J Med Genet A. 2018 12; 176(12):2564-2574.
    View in: PubMed
    Score: 0.038
  36. The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among Hispanics. Ann Epidemiol. 2018 08; 28(8):521-528.
    View in: PubMed
    Score: 0.036
  37. Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population-based case-control study. Pediatr Blood Cancer. 2017 05; 64(5).
    View in: PubMed
    Score: 0.033
  38. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients. Cancer Epidemiol. 2016 10; 44:161-166.
    View in: PubMed
    Score: 0.033
  39. Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics. Cancer. 2016 Dec 01; 122(23):3697-3704.
    View in: PubMed
    Score: 0.032
  40. The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 09; 63(9):1557-62.
    View in: PubMed
    Score: 0.032
  41. Differences in environmental exposure assignment due to residential mobility among children with a central nervous system tumor: Texas, 1995-2009. J Expo Sci Environ Epidemiol. 2017 01; 27(1):41-46.
    View in: PubMed
    Score: 0.031
  42. Residential Radon Exposure and Incidence of Childhood Lymphoma in Texas, 1995-2011. Int J Environ Res Public Health. 2015 Sep 25; 12(10):12110-26.
    View in: PubMed
    Score: 0.030
  43. Evaluating the Role of Birth Weight and Gestational Age on Acute Lymphoblastic Leukemia Risk Among Those of Hispanic Ethnicity. Pediatr Hematol Oncol. 2015; 32(6):382-9.
    View in: PubMed
    Score: 0.030
  44. Traffic-related air pollution and the incidence of childhood central nervous system tumors: Texas, 2001-2009. Pediatr Blood Cancer. 2015 Sep; 62(9):1572-8.
    View in: PubMed
    Score: 0.030
  45. Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population-based analysis. Pediatr Blood Cancer. 2015 Oct; 62(10):1790-8.
    View in: PubMed
    Score: 0.030
  46. Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Cancer Causes Control. 2014 Jul; 25(7):905-13.
    View in: PubMed
    Score: 0.028
  47. Gene-environment interactions and the risk of childhood acute lymphoblastic leukemia: exploring the role of maternal folate genes and folic Acid fortification. Pediatr Hematol Oncol. 2014 Mar; 31(2):160-8.
    View in: PubMed
    Score: 0.027
  48. Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Int J Cancer. 2014 Jan 15; 134(2):431-6.
    View in: PubMed
    Score: 0.026
  49. Maternal variation in EPHX1, a xenobiotic metabolism gene, is associated with childhood medulloblastoma: an exploratory case-parent triad study. Pediatr Hematol Oncol. 2012 Nov; 29(8):679-85.
    View in: PubMed
    Score: 0.025
  50. A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2012 Nov; 23(11):1797-803.
    View in: PubMed
    Score: 0.025
  51. An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. Pediatr Blood Cancer. 2012 Oct; 59(4):605-10.
    View in: PubMed
    Score: 0.024
  52. Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. J Biomed Biotechnol. 2010; 2010:630940.
    View in: PubMed
    Score: 0.021
  53. Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. Clin Cancer Res. 2025 Feb 03; 31(3):457-465.
    View in: PubMed
    Score: 0.015
  54. Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia. Pharmacotherapy. 2025 Jan; 45(1):4-11.
    View in: PubMed
    Score: 0.014
  55. Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatr Blood Cancer. 2025 Mar; 72(3):e31477.
    View in: PubMed
    Score: 0.014
  56. A family-based approach to cascade genetic testing in a pediatric cancer genetics clinic. Fam Cancer. 2024 Nov 20; 24(1):8.
    View in: PubMed
    Score: 0.014
  57. Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies. Clin Cancer Res. 2024 Nov 01; 30(21):4834-4843.
    View in: PubMed
    Score: 0.014
  58. Delayed excretion of high-dose methotrexate in pediatric acute leukemia correlates with laxative and constipation management. Pediatr Blood Cancer. 2025 Jan; 72(1):e31377.
    View in: PubMed
    Score: 0.014
  59. Folate Metabolism and Risk of Childhood Acute Lymphoblastic Leukemia: A Genetic Pathway Analysis from the Childhood Cancer and Leukemia International Consortium. Cancer Epidemiol Biomarkers Prev. 2024 Sep 03; 33(9):1248-1252.
    View in: PubMed
    Score: 0.014
  60. Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma? Am J Clin Oncol. 2025 Jan 01; 48(1):21-27.
    View in: PubMed
    Score: 0.014
  61. Splenic complications in pediatric sickle cell disease: A retrospective cohort review. Pediatr Blood Cancer. 2024 Oct; 71(10):e31219.
    View in: PubMed
    Score: 0.014
  62. Epidemiological trends of synovial sarcoma by primary tumor sites in the US from 2000 to 2020. Cancer Epidemiol. 2024 Oct; 92:102627.
    View in: PubMed
    Score: 0.014
  63. Langerhans cell histiocytosis in children born after assisted reproductive technology. Reprod Biomed Online. 2024 Dec; 49(6):104379.
    View in: PubMed
    Score: 0.014
  64. Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020. Cancer Epidemiol. 2024 Oct; 92:102610.
    View in: PubMed
    Score: 0.014
  65. PM2.5, vegetation density, and childhood cancer: a case-control registry-based study from Texas 1995-2011. J Natl Cancer Inst. 2024 Jun 07; 116(6):876-884.
    View in: PubMed
    Score: 0.014
  66. Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test? Clin Cancer Res. 2024 May 01; 30(9):1733-1738.
    View in: PubMed
    Score: 0.014
  67. Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer. J Clin Oncol. 2024 Jul 01; 42(19):2306-2316.
    View in: PubMed
    Score: 0.014
  68. Congenital Tooth Agenesis and Risk of Early-Onset Cancer. JAMA Netw Open. 2024 03 04; 7(3):e240365.
    View in: PubMed
    Score: 0.014
  69. Common epilepsy variants from the general population are not associated with epilepsy among individuals with tuberous sclerosis complex. Am J Med Genet A. 2024 06; 194(6):e63569.
    View in: PubMed
    Score: 0.014
  70. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. J Natl Cancer Inst. 2023 11 08; 115(11):1337-1354.
    View in: PubMed
    Score: 0.013
  71. A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019. Pediatr Blood Cancer. 2024 Jan; 71(1):e30732.
    View in: PubMed
    Score: 0.013
  72. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors. Neuro Oncol. 2023 09 05; 25(9):1698-1708.
    View in: PubMed
    Score: 0.013
  73. Management of Down Syndrome-Associated Leukemias: A Review. JAMA Oncol. 2023 09 01; 9(9):1283-1290.
    View in: PubMed
    Score: 0.013
  74. A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma. Pediatr Blood Cancer. 2023 11; 70(11):e30651.
    View in: PubMed
    Score: 0.013
  75. Associations between birth defects with neural crest cell origins and pediatric embryonal tumors. Cancer. 2023 11 15; 129(22):3595-3602.
    View in: PubMed
    Score: 0.013
  76. Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site. Cancer. 2023 10 15; 129(20):3300-3308.
    View in: PubMed
    Score: 0.013
  77. Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group. Cancer Med. 2023 06; 12(11):12777-12791.
    View in: PubMed
    Score: 0.013
  78. Characteristics of infections and their risk factors in children with biliary atresia. Clin Res Hepatol Gastroenterol. 2023 04; 47(4):102109.
    View in: PubMed
    Score: 0.013
  79. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy. 2023 03; 43(3):205-214.
    View in: PubMed
    Score: 0.013
  80. Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis. Cancer. 2023 04 15; 129(8):1276-1286.
    View in: PubMed
    Score: 0.013
  81. Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate. Cancer. 2023 04 15; 129(8):1287-1294.
    View in: PubMed
    Score: 0.013
  82. Innate immune cell dysfunction and systemic inflammation in children with chronic liver diseases undergoing transplantation. Am J Transplant. 2023 01; 23(1):26-36.
    View in: PubMed
    Score: 0.013
  83. Leveraging Clinical Trial Populations and Data from the Children's Oncology Group for Cancer Survivorship Research. Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1675-1682.
    View in: PubMed
    Score: 0.012
  84. Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2022 12; 63(12):2948-2954.
    View in: PubMed
    Score: 0.012
  85. Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome. Blood Adv. 2022 07 26; 6(14):4132-4136.
    View in: PubMed
    Score: 0.012
  86. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group. Lancet Haematol. 2022 Sep; 9(9):e678-e688.
    View in: PubMed
    Score: 0.012
  87. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. Eur J Cancer. 2022 09; 172:367-386.
    View in: PubMed
    Score: 0.012
  88. Prevalence and Clustering of Congenital Heart Defects Among Boys With Hypospadias. JAMA Netw Open. 2022 07 01; 5(7):e2224152.
    View in: PubMed
    Score: 0.012
  89. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer. 2022 10; 69(10):e29763.
    View in: PubMed
    Score: 0.012
  90. A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment. Haematologica. 2022 05 01; 107(5):1185-1188.
    View in: PubMed
    Score: 0.012
  91. Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy. Pediatr Blood Cancer. 2022 06; 69(6):e29645.
    View in: PubMed
    Score: 0.012
  92. Residence in a Latinx enclave and end-induction minimal residual disease positivity among children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2022 Oct; 39(7):650-657.
    View in: PubMed
    Score: 0.012
  93. A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers. Pediatr Hematol Oncol. 2022 Apr; 39(3):193-202.
    View in: PubMed
    Score: 0.012
  94. Neighborhood Socioeconomic Deprivation and Mortality in Children with Central Nervous System Tumors. Cancer Epidemiol Biomarkers Prev. 2021 12; 30(12):2278-2285.
    View in: PubMed
    Score: 0.012
  95. Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia. Sci Rep. 2021 10 04; 11(1):19613.
    View in: PubMed
    Score: 0.012
  96. Parental perceptions of genetic testing for children with autism spectrum disorders. Am J Med Genet A. 2022 01; 188(1):178-186.
    View in: PubMed
    Score: 0.012
  97. The frequency and efficacy of genetic testing in individuals with scimitar syndrome. Cardiol Young. 2022 Apr; 32(4):550-557.
    View in: PubMed
    Score: 0.011
  98. Synovial Sarcoma of the Hand and Foot: An Institutional Review. Am J Clin Oncol. 2021 07 01; 44(7):361-368.
    View in: PubMed
    Score: 0.011
  99. A retrospective analysis of growth hormone therapy in children with Schaaf-Yang syndrome. Clin Genet. 2021 09; 100(3):298-307.
    View in: PubMed
    Score: 0.011
  100. Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis. Sci Rep. 2021 05 17; 11(1):10410.
    View in: PubMed
    Score: 0.011
  101. Operational Definitions for Chronic Liver Disease Manifestations and Recurring Clinical Events in Biliary Atresia. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):584-591.
    View in: PubMed
    Score: 0.011
  102. Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatr Blood Cancer. 2021 08; 68(8):e29036.
    View in: PubMed
    Score: 0.011
  103. Patterns of congenital anomalies among individuals with trisomy 13 in Texas. Am J Med Genet A. 2021 06; 185(6):1787-1793.
    View in: PubMed
    Score: 0.011
  104. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. JCO Precis Oncol. 2021; 5.
    View in: PubMed
    Score: 0.011
  105. Prevalence of structural birth defects among infants with Down syndrome, 2013-2017: A US population-based study. Birth Defects Res. 2021 01 15; 113(2):189-202.
    View in: PubMed
    Score: 0.011
  106. Neighborhood deprivation index is associated with weight status among long-term survivors of childhood acute lymphoblastic leukemia. J Cancer Surviv. 2021 10; 15(5):767-775.
    View in: PubMed
    Score: 0.011
  107. A Comprehensive Assessment of the Associations Between Season of Conception and Birth Defects, Texas, 1999-2015. Int J Environ Res Public Health. 2020 09 29; 17(19).
    View in: PubMed
    Score: 0.011
  108. Prospective patient-reported symptom profiles associated with pediatric acute lymphoblastic leukemia relapse. Support Care Cancer. 2021 May; 29(5):2455-2464.
    View in: PubMed
    Score: 0.011
  109. The relationship between chronic health conditions and cognitive deficits in children, adolescents, and young adults with down syndrome: A systematic review. PLoS One. 2020; 15(9):e0239040.
    View in: PubMed
    Score: 0.011
  110. Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia. J Pain Symptom Manage. 2021 03; 61(3):464-473.
    View in: PubMed
    Score: 0.011
  111. Cancer Risk by Attained Age among Children with Birth Defects in Arkansas. Cancer Epidemiol. 2020 10; 68:101796.
    View in: PubMed
    Score: 0.011
  112. Medical radiation exposure and risk of sporadic retinoblastoma. Pediatr Blood Cancer. 2020 11; 67(11):e28633.
    View in: PubMed
    Score: 0.011
  113. Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis Complex. Pediatr Neurol. 2020 12; 113:46-50.
    View in: PubMed
    Score: 0.011
  114. Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020 09; 67(9):e28525.
    View in: PubMed
    Score: 0.011
  115. Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2020 06 08; 37(6):867-882.e12.
    View in: PubMed
    Score: 0.011
  116. Association of population mixing and acute lymphocytic leukemia in children and young adults. Cancer Epidemiol. 2020 06; 66:101722.
    View in: PubMed
    Score: 0.010
  117. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study. PLoS One. 2020; 15(2):e0228887.
    View in: PubMed
    Score: 0.010
  118. Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2020 01 20; 38(3):232-247.
    View in: PubMed
    Score: 0.010
  119. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome. Blood. 2019 10 10; 134(15):1227-1237.
    View in: PubMed
    Score: 0.010
  120. Insights into pediatric rhabdomyosarcoma research: Challenges and goals. Pediatr Blood Cancer. 2019 10; 66(10):e27869.
    View in: PubMed
    Score: 0.010
  121. Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis. PLoS One. 2019; 14(5):e0217932.
    View in: PubMed
    Score: 0.010
  122. Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma. Cancer Epidemiol. 2019 04; 59:71-74.
    View in: PubMed
    Score: 0.010
  123. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies. Genet Med. 2019 08; 21(8):1797-1807.
    View in: PubMed
    Score: 0.010
  124. Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients. Clin Cancer Res. 2018 10 15; 24(20):5012-5017.
    View in: PubMed
    Score: 0.009
  125. Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia. PLoS One. 2018; 13(5):e0197408.
    View in: PubMed
    Score: 0.009
  126. An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110.
    View in: PubMed
    Score: 0.009
  127. Evaluation of racial disparities in pediatric optic pathway glioma incidence: Results from the Surveillance, Epidemiology, and End Results Program, 2000-2014. Cancer Epidemiol. 2018 06; 54:90-94.
    View in: PubMed
    Score: 0.009
  128. Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000-2014. J Neurooncol. 2018 Aug; 139(1):69-75.
    View in: PubMed
    Score: 0.009
  129. Maternal Residential Proximity to Major Roadways and Pediatric Embryonal Tumors in Offspring. Int J Environ Res Public Health. 2018 03 13; 15(3).
    View in: PubMed
    Score: 0.009
  130. DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors. Neuro Oncol. 2017 Oct 01; 19(10):1372-1379.
    View in: PubMed
    Score: 0.009
  131. Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility. PLoS One. 2017; 12(8):e0180488.
    View in: PubMed
    Score: 0.009
  132. Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013. PLoS One. 2017; 12(6):e0179006.
    View in: PubMed
    Score: 0.009
  133. Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia. Pediatr Blood Cancer. 2017 Sep; 64(9).
    View in: PubMed
    Score: 0.008
  134. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016 Nov; 95(46):e5300.
    View in: PubMed
    Score: 0.008
  135. Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment. J Pediatr Hematol Oncol. 2016 08; 38(6):429-36.
    View in: PubMed
    Score: 0.008
  136. Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia Survivors. Cancer Nurs. 2016 Jul-Aug; 39(4):255-62.
    View in: PubMed
    Score: 0.008
  137. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma. Cancer Med. 2015 Nov; 4(11):1679-86.
    View in: PubMed
    Score: 0.008
  138. Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma? Pediatr Blood Cancer. 2016 Feb; 63(2):202-5.
    View in: PubMed
    Score: 0.008
  139. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nat Commun. 2015 Jun 24; 6:7553.
    View in: PubMed
    Score: 0.007
  140. Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database. Cancer Med. 2015 May; 4(5):781-90.
    View in: PubMed
    Score: 0.007
  141. Differentiating skin-limited and multisystem Langerhans cell histiocytosis. J Pediatr. 2014 Nov; 165(5):990-6.
    View in: PubMed
    Score: 0.007
  142. Parental military service, agent orange exposure, and the risk of rhabdomyosarcoma in offspring. J Pediatr. 2014 Dec; 165(6):1216-21.
    View in: PubMed
    Score: 0.007
  143. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev. 2014 Dec; 23(12):2716-36.
    View in: PubMed
    Score: 0.007
  144. Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015 Jan; 36(1):146-50.
    View in: PubMed
    Score: 0.007
  145. Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes. Leuk Res. 2014 Sep; 38(9):1055-60.
    View in: PubMed
    Score: 0.007
  146. Genetic markers in a multi-ethnic sample for childhood acute lymphoblastic leukemia risk. Leuk Lymphoma. 2015 Jan; 56(1):169-74.
    View in: PubMed
    Score: 0.007
  147. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014 Apr 07; 211(4):669-83.
    View in: PubMed
    Score: 0.007
  148. Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia. Leuk Res. 2013 May; 37(5):531-5.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.